Predictive Value of the Hematopoietic Stem Cell Transplantation - Comorbidity Index for Overall Survival in Patients with Multiple Myeloma
- 1 November 2022
- journal article
- research article
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 60 (5) , 468-475
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia GroupTransplantation Proceedings, 2020
- Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 yearsLeukemia & Lymphoma, 2019
- Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell TransplantationTransplantation and Cellular Therapy, 2017
- A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patientsHaematologica, 2017
- Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell TransplantationJournal of Clinical Oncology, 2014
- The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myelomaBone Marrow Transplantation, 2014
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple MyelomaTransplantation and Cellular Therapy, 2014
- Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaTransplantation and Cellular Therapy, 2008
- Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and OutcomeInfection, 2007
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003